The observation of severe phenotypes in patients whose relatively mild MRC enzymatic defect would not be expected to significantly decrease ATP production highlights the importance of increased ROS production as an underlying cause of mitochondrial disease. The gene discussed is CD200; the disease is mitochondrial disease.